The Precision Peptide Company Inc.
BPC
CNSX
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 634.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 634.88% | |||
| Cost of Revenue | -70.43% | 1,228.57% | |||
| Gross Profit | 103.10% | 344.83% | |||
| SG&A Expenses | 37.17% | 69.92% | |||
| Depreciation & Amortization | -- | 1.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.49% | 72.62% | |||
| Operating Income | -30.62% | -67.64% | |||
| Income Before Tax | 57.84% | -408.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 57.84% | -408.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.84% | -408.64% | |||
| EBIT | -30.62% | -67.64% | |||
| EBITDA | -34.07% | -64.44% | |||
| EPS Basic | 52.69% | -215.20% | |||
| Normalized Basic EPS | -39.47% | -6.54% | |||
| EPS Diluted | 52.69% | -215.20% | |||
| Normalized Diluted EPS | -39.47% | -6.54% | |||
| Average Basic Shares Outstanding | -10.90% | 60.91% | |||
| Average Diluted Shares Outstanding | -10.90% | 60.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||